-

GE Healthcare’s AIR Recon DL Technology Recognized by Popular Science Magazine in the ‘Best of What’s New’ Awards

  • AIR Recon DL is GE Healthcare’s pioneering deep-learning based technology that provides for clinical efficiency by enabling shorter scan times with higher resolution in MRI clinical procedures

CHICAGO--(BUSINESS WIRE)--GE Healthcare announced today that it was recognized in the annual ‘Best of What’s New’ awards by Popular Science Magazine. The award highlights GE Healthcare’s AIR Recon DL technology and the benefits it brings to the healthcare industry.

“We are honored to receive this award,” said Jie Xue, President and CEO, Magnetic Resonance at GE Healthcare. “AIR Recon DL was developed with the customer and patient in mind. We’re proud that we made AI part of the radiologists and technologists day-to-day imaging operations, and also enhanced the patient experience while being scanned. AIR Recon DL has benefited nearly 5.5 million patients around the world, and feedback from clinical users has been overwhelmingly positive.i

Popular Science reviews thousands of products in search of the top 100 innovations—including technologies that represent significant advancements in their categories.

“The Best of What’s New Awards are our way of celebrating the most exciting and ground-breaking innovations of the year. These awards highlight the revolutionary inventions that are helping to improve our daily lives, our society, and our planet,” says Popular Science Technology Editor Rob Verger.

GE Healthcare recently announced US FDA 510(k) clearance of its AIR Recon DL 3D and motion-insensitive PROPELLER imaging sequences. 3D imaging allows for more clinical efficiency, allowing radiologists to eliminate the need for multiple 2D acquisitions - potentially leading to faster diagnosis. Additionally, AIR Recon DL is now compatible with PROPELLER, a motion-insensitive imaging sequence particularly important for anatomies susceptible to motion such as pediatric and neurodegenerative patients, who have difficulty remaining physically still for the duration of an MRI scan. As a result, physicians can get sharper, more accurate images without the need for repeat scans – potentially translating to faster patient throughput, improved scheduling, shorter exam time, and faster diagnosis, helping to create an all-round better patient experience.

The illustration above breaks down GE Healthcare’s advanced AIR Recon DL technology in an easy-to-understand fashion that connects non-engineers/people of all ages to this exciting, industry-leading innovation.

About GE Healthcare:

GE Healthcare is the $17.7 billion healthcare business of GE (NYSE: GE). As a leading global medical technology, pharmaceutical diagnostics and digital solutions innovator, GE Healthcare enables clinicians to make faster, more informed decisions through intelligent devices, data analytics, applications and services, supported by its Edison intelligence platform. With over 100 years of healthcare industry experience and around 48,000 employees globally, the company operates at the center of an ecosystem working toward precision health, digitizing healthcare, helping drive productivity and improve outcomes for patients, providers, health systems and researchers around the world.

Follow us on Facebook, LinkedIn, Twitter, Instagram and Insights for the latest news, or visit our website www.gehealthcare.com for more information.

iCalculated by IB data with estimation 20 scans per day, 5.5 working day in a week, fully start using AIR Recon DL 4 weeks after delivery, as of November 2022

Contacts

Maureen Oladipo
Maureen.oladipo@ge.com
+1 229 418 4479

GE Healthcare

NYSE:GE

Release Versions

Contacts

Maureen Oladipo
Maureen.oladipo@ge.com
+1 229 418 4479

More News From GE Healthcare

GE HealthCare achieves MRI portfolio milestone with FDA clearances for next-generation SIGNA MRI technology designed to enhance precision imaging and clinical efficiency

CHICAGO--(BUSINESS WIRE)--GE HealthCare (Nasdaq: GEHC) announced today 510(k) clearance of three new magnetic resonance (MR) innovations with the U.S. Food and Drug Administration (FDA): SIGNA™ Sprint with Freelium™1, a 1.5T sealed magnet MRI system; SIGNA™ Bolt2, an advanced 3T MRI scanner; and SIGNA™ One3, an AI-driven ecosystem of workflow solutions designed to help reduce inefficiencies and support MRI exams from plan to scan and beyond. The new MRI systems and technology combat some of the...

GE HealthCare builds on BARDA collaboration with approximately $35 million expansion to advance artificial intelligence-powered ultrasound for trauma care and emergency preparedness

CHICAGO--(BUSINESS WIRE)--GE HealthCare (Nasdaq: GEHC) today announced a new approximately $35 million expansion to a previous contract with the Biomedical Advanced Research and Development Authority (BARDA), part of the Administration for Strategic Preparedness and Response (ASPR) within the U.S. Department of Health and Human Services (HHS). The expansion is structured as a cost-share between BARDA and GE HealthCare, with BARDA providing the majority of funding. This jointly funded expanded a...

GE HealthCare announces cash dividend for first quarter of 2026

CHICAGO--(BUSINESS WIRE)--The Board of Directors of GE HealthCare Technologies Inc. (Nasdaq: GEHC) today declared a cash dividend of $0.035 per share of Common Stock for the first quarter of 2026 payable on May 15, 2026, to all shareholders of record as of April 3, 2026. About GE HealthCare Technologies Inc. GE HealthCare is a leading global healthcare solutions provider of advanced medical technology, pharmaceutical diagnostics, and AI, cloud and software solutions that help clinicians tackle...
Back to Newsroom